Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Adamas Pharmaceuticals Inc. (ADMS)

4.99   -0.06 (-1.19%) 05-24 16:00
Open: 5.1 Pre. Close: 5.05
High: 5.15 Low: 4.93
Volume: 488,018 Market Cap: 137M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.156 - 5.198 5.198 - 5.226
Low: 4.845 - 4.89 4.89 - 4.92
Close: 4.93 - 5.001 5.001 - 5.048

Technical analysis

as of: 2019-05-24 4:24:34 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 6.91     One year: 7.63
Support: Support1: 4.93    Support2: 4.10
Resistance: Resistance1: 5.92    Resistance2: 6.53
Pivot: 5.64
Moving Average: MA(5): 5.25     MA(20): 5.82
MA(100): 7.90     MA(250): 14.93
MACD: MACD(12,26): -0.41     Signal(9): -0.37
Stochastic oscillator: %K(14,3): 3.41     %D(3): 6.77
RSI: RSI(14): 25.36
52-week: High: 29.49  Low: 4.93  Change(%): -83.0
Average Vol(K): 3-Month: 57984  10-Days: 55199

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ADMS has closed above bottom band by 5.8%. Bollinger Bands are 32.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 14 May 2019 15:18:25 Z
Adamas (ADMS) Upgraded to Buy: Here's Why

Fri, 10 May 2019 00:56:31 Z
Adamas Pharmaceuticals (ADMS) Reports Q1 Loss, Lags Revenue Estimates

Thu, 25 Apr 2019 17:27:41 Z
Will Adamas Pharmaceuticals (ADMS) Report Negative Q1 Earnings? What You Should Know

Tue, 05 Mar 2019 21:21:27 Z
Mid-Afternoon Market Update: YY Rises After Q4 Results; Atlas Financial Shares Fall

Tue, 05 Mar 2019 21:06:50 Z
Health Care Sector Update for 03/05/2019: PMD,ACB,ACB.TO,AMRN,ADMS

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 27.53
Shares Float (M) 26.90
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -4.890
EPS Est. Current Year -3.770
EPS Est. Next Year -3.420
EPS Est. Next Quarter -1.170
Forward EPS -3.948
Book Value (p.s.) 2.570
PEG Ratio -0.08
Profit Margin
Operating Margin -256.38
Return on Assets (ttm) -50.8
Return on Equity (ttm) -115.1
Qtrly Rev. Growth 356.9
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -100.34
Levered Free Cash Flow (M) -69.36

Stock Valuations

P/E -1.02
P/E Growth Ratio -0.01
P/BV 1.94
P/S 86946008.00
P/CF -1.37

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.